Varicella Vaccine Safety: Absence of Evidence Is Not Evidence of Absence. [PDF]
Lee J.
europepmc +1 more source
A Variant Allele in Varicella-Zoster Virus Glycoprotein B Selected during Production of the Varicella Vaccine Contributes to Its Attenuation. [PDF]
Sadaoka T +5 more
europepmc +1 more source
Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Healthy Children Aged 12 to 15 Months: A Phase III, Randomized, Double-Blind, Active-Controlled Clinical Trial. [PDF]
Nazaire-Bermal N +8 more
europepmc +1 more source
Varicella Vaccine: Rare Serious Problems—but the Benefits Still Outweigh the Risks [PDF]
Anne A. Gershon
openalex +1 more source
Correction: Wang et al. Immune Persistence Following a Single Dose of Varicella Vaccine: 5-Year and 8-Year Follow-Up of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial. <i>Vaccines</i> 2025, <i>13</i>, 1024. [PDF]
Wang Y +6 more
europepmc +1 more source
Transmission of Vaccine Strain Varicella‐Zoster Virus from a Healthy Adult with Vaccine‐Associated Rash to Susceptible Household Contacts [PDF]
Philip LaRussa +3 more
openalex +1 more source
Varicella vaccine effectiveness evaluation in Wuxi, China: A retrospective cohort study. [PDF]
Xiu S +6 more
europepmc +1 more source
Surveillance of Adverse Events Following Varicella Vaccine Immunization in Zhejiang Province, China, from 2020 to 2022. [PDF]
Liang H, Qi X, Chen Y, Pan X.
europepmc +1 more source
Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus. [PDF]
Heusel EH, Grose C.
europepmc +1 more source

